FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2003459715> ?p ?o ?g. }

• W2003459715 endingPage "503" @default.
• W2003459715 startingPage "495" @default.
• W2003459715 abstract "Effective vascular normalisation following vascular endothelial growth factor (VEGF) inhibition is associated with endothelial cell regression leaving empty basement membrane sleeves (BMS). These long-lived BMS permit the rapid regrowth of tumour vasculature upon treatment cessation and promote resistance to VEGF-targeting drugs. Previous attempts at removing BMS have failed. Angiopoietin-2 (Ang2) is a vascular destabilizing factor that antagonises normalisation. We hypothesised that Ang2 inhibition could permit vascular normalisation at significantly reduced doses of VEGF inhibition, avoiding excessive vessel regression and the formation of empty BMS.Mice xenografted with human colorectal cancer cells (LS174T) were treated with low (0.5 mg kg(-1)) or high (5 mg kg(-1)) doses of the VEGF-targeting antibody bevacizumab with or without an Ang2 blocking peptibody L1-10. Tumour growth, BMS formation and normalisation parameters were examined including vessel density, pericyte coverage, adherence junctions, leakiness, perfusion, hypoxia and proliferation.Dual targeting of VEGF and Ang2 achieved effective normalisation at only one-tenth of the dose required with bevacizumab alone. Pericyte coverage, vascular integrity, adherence junctions and perfusion as prerequisites for improved access of chemotherapy were improved without inducing empty BMS that facilitate rapid vascular regrowth.Dual targeting of VEGF and Ang2 can potentiate the effectiveness of VEGF inhibitors and avoid the formation of empty BMS." @default.
• W2003459715 created "2016-06-24" @default.
• W2003459715 creator A5019015316 @default.
• W2003459715 creator A5030213504 @default.
• W2003459715 creator A5051152518 @default.
• W2003459715 creator A5051323607 @default.
• W2003459715 creator A5066245661 @default.
• W2003459715 creator A5070224162 @default.
• W2003459715 creator A5073459990 @default.
• W2003459715 creator A5076077834 @default.
• W2003459715 date "2015-01-06" @default.
• W2003459715 modified "2023-10-17" @default.
• W2003459715 title "Dual targeting of Angiopoetin-2 and VEGF potentiates effective vascular normalisation without inducing empty basement membrane sleeves in xenograft tumours" @default.
• W2003459715 cites W1603230122 @default.
• W2003459715 cites W1968014316 @default.
• W2003459715 cites W1974150165 @default.
• W2003459715 cites W1977887541 @default.
• W2003459715 cites W1989402742 @default.
• W2003459715 cites W1996810856 @default.
• W2003459715 cites W2002268410 @default.
• W2003459715 cites W2012063336 @default.
• W2003459715 cites W2012852444 @default.
• W2003459715 cites W2016861891 @default.
• W2003459715 cites W2017322644 @default.
• W2003459715 cites W2026184172 @default.
• W2003459715 cites W2039893214 @default.
• W2003459715 cites W2042350316 @default.
• W2003459715 cites W2073212944 @default.
• W2003459715 cites W2080162976 @default.
• W2003459715 cites W2080202443 @default.
• W2003459715 cites W2096415778 @default.
• W2003459715 cites W2099028752 @default.
• W2003459715 cites W2100891986 @default.
• W2003459715 cites W2101680696 @default.
• W2003459715 cites W2107252679 @default.
• W2003459715 cites W2117530284 @default.
• W2003459715 cites W2135385911 @default.
• W2003459715 cites W2136023563 @default.
• W2003459715 cites W2144893998 @default.
• W2003459715 cites W2145267522 @default.
• W2003459715 cites W2145441158 @default.
• W2003459715 cites W2145835533 @default.
• W2003459715 cites W2157769714 @default.
• W2003459715 cites W2157985193 @default.
• W2003459715 cites W2158642531 @default.
• W2003459715 cites W2162352067 @default.
• W2003459715 cites W2166215138 @default.
• W2003459715 cites W2170286781 @default.
• W2003459715 doi "https://doi.org/10.1038/bjc.2014.629" @default.
• W2003459715 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4453651" @default.
• W2003459715 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25562438" @default.
• W2003459715 hasPublicationYear "2015" @default.
• W2003459715 type Work @default.
• W2003459715 sameAs 2003459715 @default.
• W2003459715 citedByCount "29" @default.
• W2003459715 countsByYear W20034597152015 @default.
• W2003459715 countsByYear W20034597152016 @default.
• W2003459715 countsByYear W20034597152017 @default.
• W2003459715 countsByYear W20034597152018 @default.
• W2003459715 countsByYear W20034597152019 @default.
• W2003459715 countsByYear W20034597152020 @default.
• W2003459715 countsByYear W20034597152021 @default.
• W2003459715 countsByYear W20034597152022 @default.
• W2003459715 countsByYear W20034597152023 @default.
• W2003459715 crossrefType "journal-article" @default.
• W2003459715 hasAuthorship W2003459715A5019015316 @default.
• W2003459715 hasAuthorship W2003459715A5030213504 @default.
• W2003459715 hasAuthorship W2003459715A5051152518 @default.
• W2003459715 hasAuthorship W2003459715A5051323607 @default.
• W2003459715 hasAuthorship W2003459715A5066245661 @default.
• W2003459715 hasAuthorship W2003459715A5070224162 @default.
• W2003459715 hasAuthorship W2003459715A5073459990 @default.
• W2003459715 hasAuthorship W2003459715A5076077834 @default.
• W2003459715 hasBestOaLocation W20034597151 @default.
• W2003459715 hasConcept C113045295 @default.
• W2003459715 hasConcept C123012128 @default.
• W2003459715 hasConcept C126322002 @default.
• W2003459715 hasConcept C142724271 @default.
• W2003459715 hasConcept C146285616 @default.
• W2003459715 hasConcept C146957229 @default.
• W2003459715 hasConcept C167734588 @default.
• W2003459715 hasConcept C178790620 @default.
• W2003459715 hasConcept C185592680 @default.
• W2003459715 hasConcept C202751555 @default.
• W2003459715 hasConcept C2776193487 @default.
• W2003459715 hasConcept C2776694085 @default.
• W2003459715 hasConcept C2777025900 @default.
• W2003459715 hasConcept C2777802072 @default.
• W2003459715 hasConcept C2780394083 @default.
• W2003459715 hasConcept C2780427682 @default.
• W2003459715 hasConcept C502942594 @default.
• W2003459715 hasConcept C540031477 @default.
• W2003459715 hasConcept C55493867 @default.
• W2003459715 hasConcept C71924100 @default.
• W2003459715 hasConcept C7836513 @default.
• W2003459715 hasConcept C85219853 @default.
• W2003459715 hasConcept C98274493 @default.
• W2003459715 hasConceptScore W2003459715C113045295 @default.

• next